SWR/J transgenic (tg) mice were generated expressing the TCR beta chain derived from an anticollagen type II (CII) arthritogenic T cell clone. The SWR/J strain was selected because it is resistant to collagen-induced arthritis (CIA) and lacks the V beta gene segment used by the T cell clone. Expression of the tg beta chain on all thymocytes and peripheral lymph node T cells led to a more efficient anti-CII immune response, but did not confer CIA susceptibility to SWR/J mice. Nevertheless, this tg beta chain enhanced predisposition to CIA as (DBA/1 x SWR) F1 beta tg mice were more susceptible than normal F1 littermates. Our results demonstrate that the expression of the tg beta chain contributes to CIA susceptibility, but by itself it is not sufficient to overcome CIA resistance in the SWR/J strain.
Skip Nav Destination
Article navigation
1 August 1992
Article|
August 01 1992
Expression of a transgenic T cell receptor beta chain enhances collagen-induced arthritis.
L Mori,
L Mori
Pharmaceutical Research New Technologies, F. Hoffmann-La Roche, Ltd., Basel, Switzerland.
Search for other works by this author on:
H Loetscher,
H Loetscher
Pharmaceutical Research New Technologies, F. Hoffmann-La Roche, Ltd., Basel, Switzerland.
Search for other works by this author on:
K Kakimoto,
K Kakimoto
Pharmaceutical Research New Technologies, F. Hoffmann-La Roche, Ltd., Basel, Switzerland.
Search for other works by this author on:
H Bluethmann,
H Bluethmann
Pharmaceutical Research New Technologies, F. Hoffmann-La Roche, Ltd., Basel, Switzerland.
Search for other works by this author on:
M Steinmetz
M Steinmetz
Pharmaceutical Research New Technologies, F. Hoffmann-La Roche, Ltd., Basel, Switzerland.
Search for other works by this author on:
L Mori
Pharmaceutical Research New Technologies, F. Hoffmann-La Roche, Ltd., Basel, Switzerland.
H Loetscher
Pharmaceutical Research New Technologies, F. Hoffmann-La Roche, Ltd., Basel, Switzerland.
K Kakimoto
Pharmaceutical Research New Technologies, F. Hoffmann-La Roche, Ltd., Basel, Switzerland.
H Bluethmann
Pharmaceutical Research New Technologies, F. Hoffmann-La Roche, Ltd., Basel, Switzerland.
M Steinmetz
Pharmaceutical Research New Technologies, F. Hoffmann-La Roche, Ltd., Basel, Switzerland.
Online ISSN: 1540-9538
Print ISSN: 0022-1007
J Exp Med (1992) 176 (2): 381–388.
Citation
L Mori, H Loetscher, K Kakimoto, H Bluethmann, M Steinmetz; Expression of a transgenic T cell receptor beta chain enhances collagen-induced arthritis.. J Exp Med 1 August 1992; 176 (2): 381–388. doi: https://doi.org/10.1084/jem.176.2.381
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionEmail alerts
Advertisement